Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide. - Wikidata - awgldk - TriplyDB

Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.

Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.

http://www.wikidata.org/entity/Q37699699

about

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.

P2860

Q45974877-AC189546-E6BC-4F84-AB46-CFF09A8891C8

P2860

Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.

http://www.wikidata.org/entity/Q37699699

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Edoxaban in Atrial Fibrillatio ...... nd Answers: A Practical Guide.

@en

Edoxaban in Atrial Fibrillatio ...... nd Answers: A Practical Guide.

@nl

type

label

Edoxaban in Atrial Fibrillatio ...... nd Answers: A Practical Guide.

@en

Edoxaban in Atrial Fibrillatio ...... nd Answers: A Practical Guide.

@nl

prefLabel

Edoxaban in Atrial Fibrillatio ...... nd Answers: A Practical Guide.

@en

Edoxaban in Atrial Fibrillatio ...... nd Answers: A Practical Guide.

@nl

P1433

Q37699699-E66BA781-20C3-48B0-A14F-EFAC2DB46E04

P1476

Q37699699-771F7F4D-4406-410F-97C8-85B1522DA6E7

P2093

Q37699699-32643573-AB45-4E4F-AF8D-53AEA24BDA29

Q37699699-6EB36D01-0969-4061-B12B-49E00A76724D

Q37699699-7A08C4F2-DA6C-4968-8C37-ABA15F14FA07

Q37699699-84838034-3802-40D1-A9AC-9D3F7D1A876F

Q37699699-999B0E04-DD5B-4283-949E-01FE813DD5C7

Q37699699-B45B44C1-7998-4839-BC10-745B7477F5C8

Q37699699-BAC518DE-D0C2-4889-AF11-85D124782126

Q37699699-DA30788D-3C5D-43A0-A812-127D08553E85

P2860

Q37699699-0A15D4EF-801A-4404-B56E-01C1DCA679B3

Q37699699-0AFB9392-E9B6-4DCF-B6FF-A06631F7D73E

Q37699699-0D0B8340-587E-4964-87CA-E1351FF1F3FA

Q37699699-0E4841CB-5857-403C-8CFA-FCF78D015157

Q37699699-16E941E3-ED51-4A7D-8C32-53155A6357FB

Q37699699-1BB2002A-9914-4B17-85A6-3FA5E42F492D

Q37699699-1E3B20DC-7A7B-4929-A48F-12930CD52625

Q37699699-2705C522-0C2B-4440-9AAE-F375422DCB43

Q37699699-280BCF47-AB46-4B34-8659-B8230304F780

Q37699699-46C8B530-E247-40B8-9C00-0B4DAE7DA4CA

P2888

Q37699699-2178F02E-1062-411A-91DF-F0DF2377DFE8

P304

Q37699699-429B2E8D-D9A3-46C5-BD67-01C66BE48A1A

P31

Q37699699-AEFF8BBF-06DD-43F9-A823-957DD1B90F4C

P356

Q37699699-2349D94E-B390-4419-8266-B7AD8AC22E6A

P407

Q37699699-834A1F81-1416-4170-A51D-DFDDD8B33781

P433

Q37699699-8C93F642-40B2-4FB8-9AEA-80D2713C08B9

P478

Q37699699-2AB114BC-830D-4B94-B8D5-ADE0F59C3D99

P50

Q37699699-3AFF19FE-333F-4246-81DD-3D4247100E37

Q37699699-91484152-FF96-406F-8501-7BF439B6FD7D

P577

Q37699699-EF67474D-C6FC-406D-9905-06875C1AE4F2

P698

Q37699699-AC3BAFCE-0F71-4B16-9634-B0F11E4FFF7D

P921

Q37699699-13A42C14-B802-4AC7-8EF8-619747403C8F

Q37699699-AF6A6853-4C79-407D-A6BD-8813F871CE34

Q37699699-E75FF89B-2F0D-4707-82E7-94DFAFF977D3

P932

Q37699699-F33074BA-BF41-42CB-8498-5FD8B91E1AF1

P356

S12325-017-0488-9

P1433

Advances in Therapy

P1476

Edoxaban in Atrial Fibrillatio ...... and Answers: A Practical Guide

@en

P2093

Andrea Rubboli

http://www.w3.org/2001/XMLSchema#string

Angelo Ghirarduzzi

http://www.w3.org/2001/XMLSchema#string

Giancarlo Agnelli

http://www.w3.org/2001/XMLSchema#string

Giuseppe Boriani

http://www.w3.org/2001/XMLSchema#string

Giuseppe Patti

http://www.w3.org/2001/XMLSchema#string

Piercarla Schinco

http://www.w3.org/2001/XMLSchema#string

Roberta Rossini

http://www.w3.org/2001/XMLSchema#string

Walter Ageno

http://www.w3.org/2001/XMLSchema#string

P2860

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism

Dabigatran versus warfarin in patients with atrial fibrillation

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

Initial treatment of venous thromboembolism.

Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

P2888

s12325-017-0488-9

P304

620-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-017-0488-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Raffaele De Caterina

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28194578

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

atrial fibrillation

P932

5350200

http://www.w3.org/2001/XMLSchema#string